Myomo (MYO) Cash & Equivalents (QoQ) (2016 - 2025)
Myomo (MYO) Cash & Equivalents (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Myomo | 74.64 Mn | 55.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.76% |
| Sep 30, 2025 | -16.49% |
| Jun 30, 2025 | -23.24% |
| Mar 31, 2025 | -18.50% |
| Dec 31, 2024 | 253.65% |
| Sep 30, 2024 | 19.70% |
| Jun 30, 2024 | 7.57% |
| Mar 31, 2024 | -20.91% |
| Dec 31, 2023 | -0.59% |
| Sep 30, 2023 | -22.83% |
| Jun 30, 2023 | -3.31% |
| Mar 31, 2023 | 73.28% |
| Dec 31, 2022 | -27.95% |
| Sep 30, 2022 | -27.51% |
| Jun 30, 2022 | -20.91% |
| Mar 31, 2022 | -16.63% |
| Dec 31, 2021 | 23.14% |
| Sep 30, 2021 | -8.46% |
| Jun 30, 2021 | -20.72% |
| Mar 31, 2021 | 41.91% |